CRISPR Therapeutics Announces Two-Year Collaboration Agreement with Massachusetts General Hospital – JD Supra (press release)
|
CRISPR Therapeutics Announces Two-Year Collaboration Agreement with Massachusetts General Hospital
JD Supra (press release) CRISPR Therapeutics and Massachusetts General Hospital Cancer Center (MGHCC) have entered into a two-year research collaboration and license option agreement to develop novel T-cell therapies for cancer. CRISPR/Cas9 gene editing will be utilised to … |
